Please login to the form below

Not currently logged in
Email:
Password:

compulsory licensing

This page shows the latest compulsory licensing news and features for those working in and with pharma, biotech and healthcare.

Roche blocks Herceptin biosimilar in India

Roche blocks Herceptin biosimilar in India

Herceptin has been an intellectual property (IP) battleground in India, with threats of compulsory licensing eventually causing Roche to relinquish its patents on the drug in India, clearing the path for

Latest news

More from news
Approximately 1 fully matching, plus 19 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kantar Health

Kantar Health is a leading global healthcare consulting firm and trusted advisor to many of the world’s leading pharmaceutical, biotech,...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics